Topic: Revisiting low-lactate culture media 5 years later – how to make it work for your lab Speaker: Matthew ‘Tex’ VerMilyea, PhD, HCLD/CC (ABB) on behalf of Lindsey VerMilyea, MSc (Austin, Texas, USA)
Topic: A Clearer Picture of Embryo Viability with AI-based Technology Speaker: Michelle Perugini, PhD (San Francisco, California, California, USA) Speaker: Nuria Soler, PhD (Alicante, Spain) Speaker: Matthew ‘Tex’ VerMilyea, PhD, HCLD/CC (ABB) (Austin, Texas, USA)
IVF regulations worldwide are continuously changing. In this workshop from ESHRE 2022, Marlin Frechette reviews recent changes in the European Standards and what our organization is doing as a company to meet the Medical Device Regulations (MDR) requirements to continue providing products to customers without interruption.
In this presentation made at BPI West 2022, Tom Fletcher, R&D Director, Process Development, FUJIFILM Irvine Scientific discusses the many benefits of the new Manufacturing Science and Technology (MSAT) service. MSAT can help to develop user-friendly cell culture media for late-stage development, and the manufacturing of biologic drug substances and cell and gene therapies, identify opportunities for practical improvement of existing solution preparation processes, and simplify media preparation methods and improving solubility of powdered media.
In this presentation, given at BPI EU 2021, Tom Fletcher, R&D Director, Process Sciences, introduces the new Manufacturing Science and Technology (MSAT) service, which was created in response to the needs of biopharmaceutical manufacturers for better cell culture media preparation methods. Whether the needs are to reduce cost, save time, or improve reliability, the MSAT service helps identify opportunities for practical improvement of existing solution preparation processes. Case studies are provided as examples of various approaches.
Topic: Life Whisperer Viability Webinar Series Presenter: Dr. Michelle Perugini, Founder & CEO of Presagen Presenter: Matthew VerMilyea, PhD, HCLD/CC (ABB); Vice President of Scientific Advancement – Ovation Fertility; Scientific Director – Texas Fertility Centers; Laboratory and Operations Director – Ovation Fertility Austin & San Antonio Presenter: Adelle Lim, MSc Posted in: Assisted Reproductive Technology
Watch this webinar to gain a deeper understanding of how an AI-based tool can significantly improve embryo assessment. Life Whisperer Viability, an objective, non invasive web application that uses AI-based analysis to assess embryo viability can significantly improve your confidence in the embryo selection process.
At the 2021 Multi-Functional Cell Therapies (MFCT) Summit, Robert Newman, PhD, CSO, FUJIFILM Irvine Scientific, presented innovative approaches that his R&D team uses to select and optimize versatile, chemically defined media, as well as how these efforts drive the successful development and production of combination biotherapies.
Session: Leading the Way in IVF through Innovative Solutions Chair: Robert Newman, PhD, Chief Scientific Officer, FUJIFILM Irvine Scientific Presenter: Nadir Ciray, PhD, R&D Director – ART, FUJIFILM Irvine Scientific Presenter: Matthew (Tex) VerMilyea, PhD, HCLD/CC (ABB), Vice President of Scientific Advancement, Ovation Fertility Posted in: Assisted Reproductive Technology
Topic: Developing and Understanding Perfusion Processes Presented by: Véronique Chotteau, Principal Investigator of the Cell Technology Group, KTH Royal Institute of Technology Presented by: Tom Fletcher, Director – Process Development, FUJIFILM Irvine Scientific Posted in: Bioproduction
This session, which was part of the BPI Fall Digital Week Webinar Series, features recent results from insightful studies conducted at KTH Royal Institute of Technology in Stockholm, along with an update on efforts to develop superior chemically-defined cell culture media from FUJIFILM Irvine Scientific.
The transportation of cryopreserved specimens, especially those that are slow-frozen, is a routine activity for most IVF laboratories. In this webinar, led by Dr. Dunja Baston-Büst, we focus on the transportation of vitrified specimens that are particularly sensitive to their surroundings—and discuss the specific conditions and steps that should be taken to help ensure their intact transport and storage.
In this webinar, Holden Harris shares a behind the scenes look into our assisted reproductive technology (ART) media development process, providing insight into work done during product design and testing during design control. Get a closer look into how we ensure that our media meets rigorous quality, safety, and performance criteria before going to market.
This webinar explores the specific regulatory requirements of different regions (including analysis of the amount of time the regulatory approval process takes in each case), and the critical quality attributes (CQAs) of cell therapy raw and starting materials.
In this webinar, Joseph Conaghan, PhD, and Nadir Ciray, PhD, discuss the basics of vitrification media components and review how vitrification media has evolved to suit the needs of the modern IVF laboratory.
In this webinar, Joseph Conaghan, PhD, shares some helpful tips on how to simplify procedures in micromanipulation, oocyte vitrification and embryo culture in order to maximize successful outcomes in the IVF laboratory.
In this webinar, Yannis Panagiotidis, discusses closed system vitrification.
Session: Next Generation Embryo Culture and Vitrification Systems Chair: Yannis Panagiotidis, PhD, Head of IVF Lab, Lakentro IVF Unit, Thessaloniki, Greece Presenter: Yosu Franco Iriarte, PhD, Laboratory Director, Hospital Ruber International, Madrid, Spain Presenter: Ahmad Morsi Abu Maizar, M.Sc., Senior Clinical Embryologist, California Fertility Partners, Los Angeles, California USA Posted in: Assisted Reproductive Technology
Learn more about how FUJIFILM Irvine Scientific helps manufacturers through the raw materials qualification process and regional regulatory approvals, so that they can better address the challenges and opportunities on the road to bringing cell therapies to market.